BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 3491260)

  • 1. Parameters for the evaluation of IL-2 stability.
    Kenney WC; Watson E; Bartley T; Boone T; Altrock BW
    Lymphokine Res; 1986; 5 Suppl 1():S23-7. PubMed ID: 3491260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and characterization of a lyophilized dosage form of IL-1 beta.
    Visor GC; Tsai KP; Miller MD; Duffy J; Calderwood T; Lokensgard D; Killian J; Malefyt T; Gu L; Massey I
    Lymphokine Res; 1990; 9(3):425-34. PubMed ID: 2398744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stability of Ala 125 recombinant human interleukin-2 in solution.
    Reyes N; Ruiz L; Aroche K; GerĂ³nimo H; Brito O; Hardy E
    J Pharm Pharmacol; 2005 Jan; 57(1):31-7. PubMed ID: 15638990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rat interleukin-10: production and characterisation of biologically active protein in a recombinant bacterial expression system.
    Ball C; Vigues S; Gee CK; Poole S; Bristow AF
    Eur Cytokine Netw; 2001 Mar; 12(1):187-93. PubMed ID: 11282564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression and characterization of recombinant human fusion protein IL-6/IL-2 (CH925).
    Zhao C; Tang P; Wang J; Mao N; Jiang F; Li X; Liu X; Zhang M; Ren Y; Du D
    Stem Cells; 1994 May; 12(3):339-47. PubMed ID: 8075595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. pH dependent effect of glycosylation on protein stability.
    Wang W; Antonsen K; Wang YJ; Wang DQ
    Eur J Pharm Sci; 2008 Feb; 33(2):120-7. PubMed ID: 18162379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A rapid, large scale purification procedure for gibbon interleukin 2.
    Henderson LE; Hewetson JF; Hopkins RF; Sowder RC; Neubauer RH; Rabin H
    J Immunol; 1983 Aug; 131(2):810-5. PubMed ID: 6602847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioassays and biological stability.
    Wright JF
    Dev Biol Stand; 1999; 97():73-80. PubMed ID: 10463532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and purification of the recombinant diphtheria fusion toxin DT388IL3 for phase I clinical trials.
    Urieto JO; Liu T; Black JH; Cohen KA; Hall PD; Willingham MC; Pennell LK; Hogge DE; Kreitman RJ; Frankel AE
    Protein Expr Purif; 2004 Jan; 33(1):123-33. PubMed ID: 14680969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study on preparation and activity of a novel recombinant human parathyroid hormone(1-34) analog with N-terminal Pro-Pro extension.
    Chunxiao W; Jingjing L; Yire X; Min D; Zhaohui W; Gaofu Q; Xiangchun S; Xuejun W; Jie W; Taiming L
    Regul Pept; 2007 Jun; 141(1-3):35-43. PubMed ID: 17300845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studying the formation of aggregates in recombinant human granulocyte-colony stimulating factor (rHuG-CSF), lenograstim, using size-exclusion chromatography and SDS-PAGE.
    Ribarska JT; Jolevska ST; Panovska AP; Dimitrovska A
    Acta Pharm; 2008 Jun; 58(2):199-206. PubMed ID: 18515229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Studies on fermentation conditions and purification of mutant human interleukin-2 expressed in Pichia pastoris].
    Liu Y; Su C; Hu YH; Ouyang KQ; Cai SX
    Sheng Wu Gong Cheng Xue Bao; 2005 May; 21(3):430-4. PubMed ID: 16108369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A mitogenic factor, released by stimulated human mononuclear cells and distinct from interleukin 2 (IL 2), B cell growth factor (BCGF), and interleukin 1 (IL 1).
    Kasakura S; Taguchi M; Watanabe Y; Okubo T; Murachi T; Uchino H; Hanaoka M
    J Immunol; 1984 Dec; 133(6):3084-90. PubMed ID: 6238094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ubiquitous interleukin-1 alpha in fetal bovine serum may mislead the experimental results in vitro.
    Hida S; Takeuchi A; Hayashi H; Yano T; Hopkins SJ; Onozaki K
    Eur Cytokine Netw; 1995; 6(2):121-6. PubMed ID: 7578990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A bioassay to measure cytotoxicity of plasma from patients treated with mitomycin C.
    Marshall RS; Erlichman C; Rauth AM
    Cancer Res; 1985 Nov; 45(11 Pt 2):5939-43. PubMed ID: 3931911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and production of recombinant human interleukin-2 in potato plants.
    Park Y; Cheong H
    Protein Expr Purif; 2002 Jun; 25(1):160-5. PubMed ID: 12071711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production of a biologically active human interleukin 18 requires its prior synthesis as PRO-IL-18.
    Liu B; Novick D; Kim SH; Rubinstein M
    Cytokine; 2000 Oct; 12(10):1519-25. PubMed ID: 11023667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal antibodies for purification and assay of IL-2.
    Redmond S; Brady D; Clements I; Holmes-Ievers E; Hill C; Kipp D; Lawson AD; Lennox ES; Lloyd JC; Price-Jones E
    Lymphokine Res; 1986; 5 Suppl 1():S29-34. PubMed ID: 3491261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rat interleukin 6: expression in recombinant Escherichia coli, purification and development of a novel ELISA.
    Rees GS; Ball C; Ward HL; Gee CK; Tarrant G; Mistry Y; Poole S; Bristow AF
    Cytokine; 1999 Feb; 11(2):95-103. PubMed ID: 10089129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.